A prognostic model integrating clinical information and gene expression signatures in phase III neoadjuvant trial CALGB 40601(Alliance). Tanioka, Maki , Parker, Joel S , Henry, Lynn N , Tolaney, Sara ... - JSMO - Ann Oncol - 2018 Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Sequencing - CALGB-40601
